Oxidative stress transiently decreases the IKK complex (IKKα, Β, and γ), an upstream component of NF-κB signaling, after transient focal cerebral ischemia in mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 25, Issue 10, 2005, Pages 1301-1311

  Song, Yun S ^a   Lee, Yong Sun ^a   Chan, Pak H ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Focal cerebral ischemia; IKK complex; NF B signaling; Oxidative stress

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING; DNA MICROARRAY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REPERFUSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UBIQUITINATION; WILD TYPE;

ANIMALS; BRAIN ISCHEMIA; HUMANS; KINETICS; MICE; MICE, TRANSGENIC; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 25144457115     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600123     Document Type: Article

References (48)

1. Abe J-i, Okuda M, Huang Q, Yoshizumi M, Berk BC (2000) Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras. J Biol Chem 275:1739-48
2. Asai A, Tanahashi N, Qiu J-h, Saito N, Chi S, Kawahara N et al (2002) Selective proteasomal dysfunction in the hippocampal CA1 region after transient forebrain ischemia. J Cereb Blood Flow Metab 22:705-10
3. Barger SW, Mattson MP (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Brain Res Mol Brain Res 40:116-26
4. Botchkina GI, Geimonen E, Bilof ML, Villarreal O, Tracey KJ (1999) Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med 5:372-81
5. Bowler RP, Sheng H, Enghild JJ, Pearlstein RD, Warner DS, Crapo JD (2002) A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. Free Radic Biol Med 33:1141-52
6. Carroll JE, Howard EF, Hess DC, Wakade CG., Chen Q, Cheng C (1998) Nuclear factor-κB activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol Brain Res 56:186-91
7. Carter RS, Pennington KN, Ungurait BJ, Arrate P, Ballard DW (2003) Signal-induced ubiquitination of IκB kinase-β. J Biol Chem 278:48903-6
8. Chan PH (1996) Role of oxidants in ischemic brain damage. Stroke 27:1124-9
9. Chen F, Shi X (2002) Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species. Environ Health Perspect 110(Suppl 5):807-11
10. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D et al (1995) Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9:1586-97
11. Chen ZJ, Parent L, Maniatis T (1996) Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-62
12. Clemens JA (2000) Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic Biol Med 28:1526-31
13. Clemens JA, Stephenson DT, Dixon EP, Smalstig EB, Mincy RE, Rash KS et al (1997) Global cerebral ischemia activates nuclear factor-κB prior toevidence of DNA fragmentation. Brain Res Mol Brain Res 48:187-196
14. Courtois G, Smahi A, Israël A (2001) NEMO/IKKγ: linking NF-κB to human disease. Trends Mol Med 7:427-30
15. Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negativeregulation of IκB kinase activity through IKKβsubunit phosphorylation. Science 284:309-13
16. Denk A, Wirth T, Baumann B (2000) NF-κB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev 11:303-20
17. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G et al (1987) Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosageeffects in Down syndrome. Proc Natl Acad Sci USA 84:8044-8
18. Fujimura M, Morita-Fujimura Y, Kawase M, Chan PH (1999) Early decrease of apurinic/apyrimidinic endonuclease expression after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 19:495-501
19. Gabriel C, Justicia C, Camins A, Planas AM (1999) Activation of nuclear factor-κB in the rat brain after transient focal ischemia. Brain Res Mol Brain Res 65:61-9
20. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373-428
21. Hendil KB (1988) The 19 S multicatalytic 'prosome' proteinase is a constitutive enzyme in HeLa cells. Biochem Int 17:471-7
22. Henkler F, Baumann B, Fotin-Mleczek M, Weingartner M, Schwenzer R, Peters N et al (2003) Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-κB activation. J Biol Chem 278:29216-29230
23. Huang C-Y, Fujimura M, Noshita N, Chang Y-Y, Chan PH (2001) SOD1 down-regulates NF-κB and c-myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21:163-73
24. Ide T, Takada K, Qiu JH, Saito N, Kawahara N, Asai A et al (1999) Ubiquitin stress response in postischemic hippocampal neurons under nontolerant and tolerant conditions. J Cereb Blood Flow Metab 19:750-6
25. Irving EA, Hadingham SJ, Roberts J, Gibbons M, Chabot-Fletcher M, Roshak A et al (2000) Decreased nuclear factor-κB DNA binding activity following permanent focal cerebral ischaemia in the rat. Neurosci Lett 288:45-8
26. Kaltschmidt B, Sparna T, Kaltschmidt C (1999) Activation of NF-kappa B by reactive oxygen intermediates in the nervous system. Antioxid Redox Signal 1:129-44
27. Kapahi P, Takahashi T, Natoli G, Adams SR, Chen Y, Tsien RY et al (2000) Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase. J Biol Chem 275:36062-6
28. Karin M (1999) The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274:27339-42
29. Karin M, Lin A (2002) NF-κB at the crossroads of life and death. Nat Immunol 3:221-7
30. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH (1991) Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 88:11158-62
31. Li Q, Verma IM (2002) NF-κB regulation in the immune system. Nat Rev Immunol 2:725-34
32. Noshita N, Lewén A, Sugawara T, Chan PH (2001) Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21:1442-50
33. Oka S-i, Kamata H, Kamata K, Yagisawa H, Hirata H (2000) N-acetylcysteine suppresses TNF-induced NF-κB activation through inhibition of IκB kinases. FEBS Lett 472:196-202
34. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-85
35. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M et al (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. [Letter]. Nature 403:103-8
36. Rothwarf DM, Karin M (1999) The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999:RE1
37. Saito A, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH (2003) Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. J Neurosci 23:1710-8
38. Salminen A, Liu PK, Hsu CY (1995) Alteration of transcription factor binding activities in the ischemic rat-brain. Biochem Biophys Res Commun 212:939-44
39. Scheidereit C (1998) Signal transduction: docking IκB kinases. Nature 395:225-6
40. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M (1999) NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5:554-9
41. Schoonbroodt S, Piette J (2000) Oxidative stress interference with the nuclear factor-κB activation pathways. Biochem Pharmacol 60:1075-83
42. Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, Clemens J (2000) Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 20:592-603
43. Tang G, Yang J, Minemoto Y, Lin A (2001) Blocking caspase-3-mediated proteolysis of IKKβ suppresses TNF-α-induced apoptosis. Mol Cell 8:1005-16
44. Whiteside ST, Israël A (1997) IκB proteins: structure, function and regulation. Semin Cancer Biol 8:75-82
45. Wójcik C, DeMartino GN (2003) Intracellular localization of proteasomes. Int J Biochem Cell Biol 35:579-89
46. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P et al (1994) Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25:165-70
47. Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, Mattson MP (1999) Lack of the p50 subunit of nuclear factor-κB increases the vulnerability of hippocampal neurons to excitotoxic injury. J Neurosci 19:8856-65
48. Yu Z, Zhou D, Cheng G, Mattson MP (2000) Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease. J Mol Neurosci 15:31-44